SBRT Compared With IMRT Concurrently With Chemotherapy in Treating Patients With LS-SCLC
Status:
Unknown status
Trial end date:
2020-01-01
Target enrollment:
Participant gender:
Summary
As stereotactic radiotherapy (SBRT) has been widely used in clinical practice at present, the
aim of this study is to evaluate the efficacy and safety of stereotactic body radiation
therapy compared with intensity modulated radiation therapy (IMRT) concurrently with EP
regimen(cisplatin plus etoposide) in treating patients with limited-stage small cell lung
cancer